Govt Boosts Healthcare Access, Focuses on Digital & Elderly Care

Under the Ayushman Bharat framework, the Union government has continuously sought to improve the primary to tertiary care continuum. Comprehensive primary care is being ensured through more than 1.79 lakh Ayushman Arogya Mandirs, and infrastructure

AlphaMedix Shows Strong Results in GEP-NETs Phase 2 Trial

AlphaMedix (212Pb-DOTAMTATE), an investigational somatostatin receptor (SSTR)-targeted alpha therapy using the lead-212 isotope, met all primary efficacy endpoints and demonstrated clinically meaningful overall response rates (ORR) and prolonged

Lupin Launches Strategic Partnership for Injectable Platform

Nanomi B.V. (Nanomi) announced that a pharmaceutical company of global repute Lupin Limited (Lupin) has established a new strategic alliance programme which would make the long-acting injectable (LAI) platform PrecisionSphere more accessible.

Lonza Secures Swissmedic Approval for Stein Facility

Lonza, a global leader in contract development and manufacturing (CDMO), has declared that the operational readiness of its new aseptic drug product filling line at its Stein, Switzerland site is in place.

Shukra Pharma Gets Nod for Robotic Surgery Projects

Shukra Pharmaceuticals has made a remarkable step to enter the world of cutting-edge medical technology by obtaining official approval from Meril Healthcare for robotic surgery projects

Enzene Partners with Virtuosi to Advance Biologics Workforce

Enzene Biosciences Ltd., a premier Continuously Innovative Development and Manufacturing Organization (CIDMO) for biologics, has entered the immersive learning space by partnering with Virtuosi. Virtuosi have been developed by Quality Executive...

Eli Lilly's Omvoh sustains UC efficacy and safety for four years

Eli Lilly and Company has released new findings showing Omvoh (mirikizumab-mrkz) is the first and only interleukin-23p19 (IL-23p19), used for the treatment of moderately to severely active ulcerative colitis (UC) to report sustained, long-term...

NephroPlus Crosses 500 Clinics, Opens New Unit in Saharanpur

According to the Frost & Sullivan Report 2025, NephroPlus, the largest dialysis service provider in Asia, has crossed a major milestone of over 500 dialysis centers across the globe. Marking this achievement, the company announced the launch...

Sai, Centrix & Agility Form Integrated CMC Partnership

Today, Centrix Pharma Solutions, Sai Life Sciences, and Agility Life Sciences announced the formation of an Integrated CMC Partnership aimed at offering innovative biopharma firms comprehensive Chemistry, Manufacturing, and Controls (CMC) services

WHO asks India for Clarification on Coldrif Syrup Exports

According to the World Health Organisation (WHO), it is expected that a Global Medical Products Emergency Alert regarding Coldrif will be issued only after verification from Indian officials.

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.